108 related articles for article (PubMed ID: 16135164)
1. Mucociliary clearance in patients with chronic asthma: effects of beta agonists.
Daviskas E; Anderson SD; Shaw J; Eberl S; Seale JP; Yang IA; Young IH
Respirology; 2005 Sep; 10(4):426-35. PubMed ID: 16135164
[TBL] [Abstract][Full Text] [Related]
2. Effects of terbutaline in combination with mannitol on mucociliary clearance.
Daviskas E; Anderson SD; Eberl S; Chan HK; Young IH; Seale JP
Eur Respir J; 2002 Dec; 20(6):1423-9. PubMed ID: 12503699
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction.
Daviskas E; Anderson SD; Eberl S; Young IH
Respir Med; 2010 Nov; 104(11):1645-53. PubMed ID: 20576419
[TBL] [Abstract][Full Text] [Related]
4. Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis.
Mortensen J; Hansen A; Falk M; Nielsen IK; Groth S
Chest; 1993 Mar; 103(3):805-11. PubMed ID: 8095449
[TBL] [Abstract][Full Text] [Related]
5. Effect of terbutaline on mucociliary clearance in asthmatic and healthy subjects after inhalation from a pressurised inhaler and a dry powder inhaler.
Mortensen J; Groth S; Lange P; Hermansen F
Thorax; 1991 Nov; 46(11):817-23. PubMed ID: 1771605
[TBL] [Abstract][Full Text] [Related]
6. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
7. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
[TBL] [Abstract][Full Text] [Related]
8. Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects.
Cleary JC; Karmazyn Y; Mogayzel PJ; Laube BL
Pulm Pharmacol Ther; 2008; 21(1):105-11. PubMed ID: 17360209
[TBL] [Abstract][Full Text] [Related]
9. Effect of terbutaline administered from metered dose inhaler (2 mg) and subcutaneously (0.25 mg) on tracheobronchial clearance in mild asthma.
Pavia D; Agnew JE; Sutton PP; Lopez-Vidriero MT; Clay MM; Killip M; Clarke SW
Br J Dis Chest; 1987 Oct; 81(4):361-70. PubMed ID: 3329532
[TBL] [Abstract][Full Text] [Related]
10. Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects.
Daviskas E; Anderson SD; Gonda I; Eberl S; Meikle S; Seale JP; Bautovich G
Eur Respir J; 1996 Apr; 9(4):725-32. PubMed ID: 8726937
[TBL] [Abstract][Full Text] [Related]
11. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma.
Aldridge RE; Hancox RJ; Robin Taylor D; Cowan JO; Winn MC; Frampton CM; Town GI
Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139
[TBL] [Abstract][Full Text] [Related]
12. The influence of the AA 16 beta 2-adrenoceptor polymorphism on systemic and airway responses in asthma.
van Veen A; Weller FR; Wierenga EA; Jansen HM; Jonkers RE
Pulm Pharmacol Ther; 2008; 21(1):73-8. PubMed ID: 17292646
[TBL] [Abstract][Full Text] [Related]
13. Bromotyrosines in sputum proteins and treatment effects of terbutaline and budesonide in asthma.
van Dalen CJ; Aldridge RE; Chan T; Senthilmohan R; Hancox RJ; Cowan JO; Taylor DR; Town GI; Kettle AJ
Ann Allergy Asthma Immunol; 2009 Oct; 103(4):348-53. PubMed ID: 19852201
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic, cardiac, and electrolyte effects of low-dose aerosolized terbutaline sulfate in asthmatic patients.
Braden GL; Germain MJ; Mulhern JG; Hafer JG; Bria WF
Chest; 1998 Aug; 114(2):380-7. PubMed ID: 9726718
[TBL] [Abstract][Full Text] [Related]
15. Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma.
O'Connor BJ; Aikman SL; Barnes PJ
N Engl J Med; 1992 Oct; 327(17):1204-8. PubMed ID: 1357551
[TBL] [Abstract][Full Text] [Related]
16. Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma.
Bijl-Hofland ID; Cloosterman SG; Folgering HT; van den Elshout FJ; van Weel C; van Schayck CP
Am J Respir Crit Care Med; 2001 Sep; 164(5):764-9. PubMed ID: 11549530
[TBL] [Abstract][Full Text] [Related]
17. A 3-month comparison of formoterol with terbutaline via turbuhaler. A placebo-controlled study.
Ekström T; Ringdal N; Tukiainen P; Runnerström E; Soliman S
Ann Allergy Asthma Immunol; 1998 Sep; 81(3):225-30. PubMed ID: 9759798
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma.
Dal Negro RW; Micheletto C; Tognella S; Trevisan F; Guerriero M
Eur Ann Allergy Clin Immunol; 2006 May; 38(5):153-7. PubMed ID: 17058847
[TBL] [Abstract][Full Text] [Related]
19. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group.
Kerstjens HA; Brand PL; Hughes MD; Robinson NJ; Postma DS; Sluiter HJ; Bleecker ER; Dekhuijzen PN; de Jong PM; Mengelers HJ
N Engl J Med; 1992 Nov; 327(20):1413-9. PubMed ID: 1357553
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
